IMP
Process View
ovulation cycle process
A process involved in the sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "ovulation cycle process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NRP1 | neuropilin 1 | 0.650 | ||
| PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | 0.483 | ||
| MPDZ | multiple PDZ domain protein | 0.345 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.272 | ||
| CCND1 | cyclin D1 | 0.229 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.203 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.179 | ||
| EIF2B4 | eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa | 0.148 | ||
| PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 | 0.145 | ||
| PSMC5 | proteasome (prosome, macropain) 26S subunit, ATPase, 5 | 0.143 | ||
| PSMD2 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 | 0.118 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.100 | ||
| EGFR | epidermal growth factor receptor | 0.100 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.081 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.075 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.075 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.068 | ||
| TDGF1 | teratocarcinoma-derived growth factor 1 | 0.065 | ||
| TP53 | tumor protein p53 | 0.059 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.058 | ||
| PSMD13 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 | 0.058 | ||
| VEGFA | vascular endothelial growth factor A | 0.053 | Mouse | |
| NCOR2 | nuclear receptor corepressor 2 | 0.045 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.044 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.043 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.042 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.039 | Mouse Rat | |
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.038 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.036 | ||
| EP300 | E1A binding protein p300 | 0.036 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.036 | ||
| RB1 | retinoblastoma 1 | 0.036 | ||
| RNF144B | ring finger protein 144B | 0.035 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.034 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.034 | Mouse | |
| BCL2L1 | BCL2-like 1 | 0.031 | Mouse Rat | |
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.031 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.030 | ||
| SCOC | short coiled-coil protein | 0.027 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.027 | ||
| PCGF2 | polycomb group ring finger 2 | 0.026 | ||
| ESR1 | estrogen receptor 1 | 0.025 | Mouse | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.025 | ||
| CPE | carboxypeptidase E | 0.024 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.024 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.024 | ||
| INSR | insulin receptor | 0.023 | ||
| PSMC4 | proteasome (prosome, macropain) 26S subunit, ATPase, 4 | 0.023 | ||
| RNR2 | l-rRNA | 0.023 | ||
| AR | androgen receptor | 0.021 | ||
| TBP | TATA box binding protein | 0.020 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.019 | ||
| KITLG | KIT ligand | 0.019 | ||
| MYLK2 | myosin light chain kinase 2 | 0.018 | ||
| TAF12 | TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa | 0.018 | ||
| JDP2 | Jun dimerization protein 2 | 0.018 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.017 | ||
| NDP | Norrie disease (pseudoglioma) | 0.016 | ||
| ANGPT2 | angiopoietin 2 | 0.016 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.016 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.016 | ||
| NF2 | neurofibromin 2 (merlin) | 0.016 | ||
| BRCA2 | breast cancer 2, early onset | 0.015 | ||
| BAD | BCL2-associated agonist of cell death | 0.015 | ||
| GDF5 | growth differentiation factor 5 | 0.015 | ||
| SP1 | Sp1 transcription factor | 0.015 | ||
| LIMK1 | LIM domain kinase 1 | 0.014 | ||
| PSMC1 | proteasome (prosome, macropain) 26S subunit, ATPase, 1 | 0.014 | ||
| HDAC6 | histone deacetylase 6 | 0.014 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.013 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.013 | ||
| PCDHA4 | protocadherin alpha 4 | 0.013 | ||
| PSMD6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 | 0.012 | ||
| A2M | alpha-2-macroglobulin | 0.012 | ||
| SFN | stratifin | 0.012 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.012 | ||
| EIF2B5 | eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa | 0.012 | ||
| PSMD3 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 | 0.011 | ||
| IL8 | interleukin 8 | 0.011 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.011 | ||
| ACTB | actin, beta | 0.011 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.010 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.010 | Mouse |